Manager × security

Inlet Private Wealth, LLC RPRX holdings history

Who else holds this security? →

ROYALTY PHARMA PLC- CL A · CUSIP G7709Q104 · CIK 1759751

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Log in to see them.
Citable facts

As of Sep 30, 2026, Inlet Private Wealth, LLC reported 208.45K RPRX (shares), valued at $12.17M, or 2.95% of its reported non-derivative portfolio. Filed Oct 21, 2026.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
2.95%
Shares
208.45K
208,450
Reported value
$12.17M
USD

Shares decreased 1.28%; reported value increased 2.75%, and weight changed +0.07 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q3 20262.95%208,450SEC filing ↗Filed Oct 21, 2026
Q2 20262.88%211,150SEC filing ↗Filed Aug 7, 2026
Q1 20262.65%216,000SEC filing ↗Filed May 13, 2026
Q4 20252.02%225,800SEC filing ↗Filed Jan 21, 2026
Q3 20251.87%235,150SEC filing ↗Filed Oct 31, 2025
Q2 20252.08%234,840SEC filing ↗Filed Aug 5, 2025
Q1 20251.90%234,740SEC filing ↗Filed May 7, 2025
Q4 20241.60%236,740SEC filing ↗Filed Jan 24, 2025
Q3 20241.35%188,460SEC filing ↗Filed Oct 16, 2024
Q2 2024Not reportedNot reported—
Q1 2024Not reportedNot reported—
Q4 2023Not reportedNot reported—

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 2023Not reported——This security is absent from this quarter's filing; a missing record is not treated as zero holdings.—
Q1 2024Not reported——This security is absent from this quarter's filing; a missing record is not treated as zero holdings.—
Q2 2024Not reported——This security is absent from this quarter's filing; a missing record is not treated as zero holdings.—
Q3 20241.35%188,460$5.33MA comparable prior-quarter record is unavailable; changes are not inferred.SEC filing ↗
Filed Oct 16, 2024
Q4 20241.60%236,740$6.04MShares increased 25.62%; reported value increased 13.27%, and weight changed +0.25 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jan 24, 2025
Q1 20251.90%234,740$7.31MShares decreased 0.84%; reported value increased 21.00%, and weight changed +0.30 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 7, 2025
Q2 20252.08%234,840$8.46MShares increased 0.04%; reported value increased 15.79%, and weight changed +0.18 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 5, 2025
Q3 20251.87%235,150$8.30MShares increased 0.13%; reported value decreased 1.95%, and weight changed -0.21 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Oct 31, 2025
Q4 20252.02%225,800$8.72MShares decreased 3.98%; reported value increased 5.17%, and weight changed +0.15 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jan 21, 2026
Q1 20262.65%216,000$10.36MShares decreased 4.34%; reported value increased 18.76%, and weight changed +0.63 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 13, 2026
Q2 20262.88%211,150$11.84MShares decreased 2.25%; reported value increased 14.26%, and weight changed +0.23 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 7, 2026
Q3 20262.95%208,450$12.17MShares decreased 1.28%; reported value increased 2.75%, and weight changed +0.07 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Oct 21, 2026
Inlet Private Wealth, LLC · ROYALTY PHARMA PLC- CL A

Take these holdings further.

This page includes 12 of 12 reported holdings. Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_institutional_holdings
{"action":"portfolio","cik":"1759751","quarter":"2026Q3","cusip":"G7709Q104"}

akkru_institutional_holdings
{"action":"history","cik":"1759751","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP / CLI documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.